Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma

Daniel Cho; Sabina Signoretti; Sandra L. Dabora; Meredith M. Regan; Apryle Seeley; Mauro Mariotti; Amanda Youmans; Adam Polivy; Lucy Mandato; David McDermott; Eric J. Stanbridge; Michael B. Atkins

doi:10.3816/cgc.2007.n.020

Keywords

TemsirolimusTensinRenal cell carcinomaPTENMedicineInternal medicineCancer researchPathologyOncologyDiscovery and development of mTOR inhibitorsBiologyPI3K/AKT/mTOR pathwayBiochemistry

Affiliated Institutions

Related Publications

Molecular Target Class Is Predictive of <i>In vitro</i> Response Profile

Joel Greshock , Kurtis E. Bachman , Yan Degenhardt +9 more

Abstract Preclinical cellular response profiling of tumor models has become a cornerstone in the development of novel cancer therapeutics. As efforts to predict clinical efficac...

2010 Cancer Research 123 citations

Targeting PI3K/Akt signal transduction for cancer therapy

Yan He , Miao Sun , Guo Geng Zhang +4 more

The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays a crucial role in various cellular processes and is aberrantly activated in cancers, contributing to the occurrence an...

2021 Signal Transduction and Targeted Therapy 1437 citations

A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival

Benjamin D. Hopkins , Barry Fine , Nicole Steinbach +18 more

PTEN Variations The product of the tumor suppressor gene phosphate and tensin homolog on chromosome ten ( PTEN) is a lipid and protein phosphatase that regulates important cellu...

2013 Science 307 citations

Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells

Saskia M. Brachmann , Irmgard Hofmann , Christian Schnell +6 more

NVP-BEZ235 is a dual PI3K/mTOR inhibitor currently in phase I clinical trials. We profiled this compound against a panel of breast tumor cell lines to identify the patient popul...

2009 Proceedings of the National Academy o... 316 citations

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

Megan Cully , Han You , Arnold J. Levine +1 more

The tumour-suppressor phosphatase with tensin homology (PTEN) is the most important negative regulator of the cell-survival signalling pathway initiated by phosphatidylinositol ...

2006 Nature reviews. Cancer 1213 citations

Publication Info

Year: 2007
Type: article
Volume: 5
Issue: 6
Pages: 379-385
Citations: 178
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

178

OpenAlex

Cite This

APA Style

                            
                                
                                    Daniel Cho, 
                                
                                    Sabina Signoretti, 
                                
                                    Sandra L. Dabora
                                
                                et al.
                            
                            (2007). 
                            Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma. 
                            Clinical Genitourinary Cancer
                            , 5
                            (6)
                            , 379-385.
                            https://doi.org/10.3816/cgc.2007.n.020
                        

Identifiers

DOI: 10.3816/cgc.2007.n.020